• Nenhum resultado encontrado

Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study

N/A
N/A
Protected

Academic year: 2017

Share "Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study"

Copied!
5
0
0

Texto

Loading

Imagem

Figure 2 shows the linear regression data. Graphs A and B show that the coefficient of determination (R 2 ) of the rosiglitazone group was greater than that of the control group
Table 2 - Hormone values, SHBG values, and glycemia, insulin, type 1 insulin-like growth factor (IGF-1), and type 3 insulin-like growth factor-binding protein (IGFBP-3) levels of the women with PCOS in both the placebo and rosiglitazone groups (means ¡ sta

Referências

Documentos relacionados

To determine the serum IGF-1 concentrations in morbidly obese patients with normal renal function but with different types of early obesity-related glomerular lesions and to

Effect of dietary energy and protein on bovine follicular dynamics and embryo production in vitro : associations with the ovarian insulin-like growth factor system.

Assim sendo, neste anexo é feita a análise geométrica correta para o cálculo dos comprimentos dos principais tipos de estribos e de barras, fornecendo no final tabelas para serem

EMBARGOS DE DIVERGÊNCIA EM RECURSO ESPECIAL. RECURSO REPRESENTATIVO DA CONTROVÉRSIA. IMPOSTO SOBRE PRODUTOS INDUSTRIALIZADOS – IPI. INCIDÊNCIA SOBRE OS IMPORTADORES NA

Se esta relação começa na escola, é então lá que professores e outros técnicos devem trabalhar em conjunto: ―Education is becoming more interdisciplinary,

Foram feitas anotações do estande final, altura da espiga e da planta, número de espigas boas, peso de espigas com pa- lhas, peso de espiga despalhada, comprimento médio e

Soluble 34K binding protein inhib- its the binding of insulin-like grow th factor I to its cell receptors in human secretory phase endometrium: evidence for auto-

also observed inhibition of cell growth (Figure 4A) and increased activity from the IGFBP-3 promoter (Figure 4B) following administration of the PPAR c agonist rosiglitazone in PPAR